As of 2024, the AAOS Clinical Practice Guidelines (CPG) updated the evidence rating for bioinductive and bioconductive augmentation in rotator cuff repairs to ”Moderate” or “Strong.” This reflects an industry shift from mechanical fixation to biological integration.  Data from…

The Electrospinning Company was pleased to welcome representatives from DSM for a recent visit to our facilities.  The visit provided an opportunity to reinforce the long-standing relationship between our organisations and to…

The Electrospinning Company recently participated in MD&M West 2026 in Anaheim, one of the world’s leading events for medical device innovation and manufacturing. Our discussions with device manufacturers, R&D leaders, and innovation teams revealed…

Guided bone regeneration (GBR) relies on biomaterials that can create a stable environment for new bone formation while supporting the biological processes that drive healing.

At The Electrospinning Company, innovation is not only about developing advanced materials, but also about ensuring that these materials can be manufactured reliably, consistently, and at scale. 

We’re excited to welcome Scott Hayward to the team as our new Quality Manager. With more than 30 years of experience in the medical device and pharmaceutical sectors, he brings…

Katrina Moisley showcased Caladrix® tech at ITCC 2025, highlighting electrospun textiles’ role in next-gen cardiovascular medical devices.

The Electrospinning Company, a leading innovator in nanofibrous biomaterials for medical devices, has announced a strategic partnership with Avem Market Solutions to bring its advanced products to a broader range…

The Electrospinning Company and Bioinicia Fluidnatek collaborate to provide the medical device industry with unmatched levels of process development and manufacturing capability for electrospun materials and implantable devices. ELECTROSPINNING uses…

The UK patent office has issued the Kalyptix® patent (GB1914184.5) covering an immune-protective bilayer membrane. We use the Kalyptix technology platform to create implantable devices for cell therapy which act…

Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth    Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in…